Polyclonal Antibody to Fibrinogen Like Protein 1 (FGL1)    
    
FGL-1; HFREP1; HP-041; LFIRE1; Hepassocin; Hepatocyte-derived fibrinogen-related protein 1; Liver fibrinogen-related protein 1
Overview
Properties
- Product No.PAD022Ra01
 - Organism SpeciesRattus norvegicus (Rat) Same name, Different species.
 - ApplicationsIHC
If the antibody is used in flow cytometry, please check FCM antibodies.
Research use only - DownloadInstruction Manual
 - CategoryHematology
 
- SourcePolyclonal antibody preparation, Host Rabbit
 - Ig Type IgG, Potency n/a
 - PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
 - LabelNone
 - Immunogen RPD022Ra01-Recombinant Fibrinogen Like Protein 1 (FGL1)
 - Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
 - TraitsLiquid, Concentration 500µg/mL
 
Sign into your account
Share a new citation as an author
Upload your experimental result
Review

Contact us
Please fill in the blank.
Specifity
The antibody is a rabbit polyclonal antibody raised against FGL1. It has been selected for its ability to recognize FGL1 in immunohistochemical staining and western blotting.
Usage
            Western blotting: 0.5-3µg/mL;
Immunohistochemistry: 5-30µg/mL;
Immunocytochemistry: 5-30µg/mL;
Optimal working dilutions must be determined by end user.        
Storage
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
Stability
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Organism Species More: Homo sapiens (Human)Giveaways
Increment services
- 
                
                    Antibody Labeling Customized Service
                                 - 
                
                    Protein A/G Purification Column
                                 - 
                
                    Staining Solution for Cells and Tissue
                                 - 
                
                    Positive Control  for Antibody
                                 - 
                
                    Tissue/Sections Customized Service
                                 - 
                
                    Phosphorylated Antibody Customized Service
                                 - 
                
                    Western Blot (WB) Experiment Service
                                 - 
                
                    Immunohistochemistry (IHC) Experiment Service
                                 - 
                
                    Immunocytochemistry (ICC) Experiment Service
                                 - 
                
                    Flow Cytometry (FCM) Experiment Service
                                 - 
                
                    Immunoprecipitation (IP) Experiment Service
                                 - 
                
                    Immunofluorescence (IF) Experiment Service
                                 - 
                
                    Buffer
                                 - 
                
                    DAB Chromogen Kit
                                 - 
                
                    SABC Kit
                                 - 
                
                    Long-arm Biotin Labeling Kit
                                 - 
                
                    Real Time PCR Experimental Service
                                 
Citations
- The role of Hepassocin in the development of non-alcoholic fatty liver diseasePubmed: 23792031
 - Serum hepassocin concentrations in diabetic patients with or without nonalcoholic fatty liver diseaseFuturemedicine:Source
 - Compositions and Methods for Diagnosing Lung Cancery2016:0077095.html
 - Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCCDoi: 10.1016/j.cell.2018.09.053
 - Do different bariatric surgery procedures impact hepassocin plasma levels in patients with type 2 diabetes mellitus?
 - Impacts of Different Modes of Bariatric Surgery on Plasma Levels of Hepassocin in Patients with Diabetes Mellitus
 
